Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-Blind Clinical Trials

Angela Moore; Suzanne Bruce; Neil Sadick; Eduardo Tschen; Philip Werschler; Sunil Dhawan; Douglas Farsha; Michael Gold; Scott Guenthner; Steve Kempers; Leon Kircik; Jennifer Parish; Marta Rendon; Phoebe Rich; Linda Stein-Gold; Stephen Tyring; Robert Weiss; Adnan Nasir; Carsten Schmitz; Terry Boodhoo; Alexandre Kaoukhov; David Berk; Fran Cook-Bolden; Ayman Grada

doi:10.25251/skin.4.supp.51

Angela Moore
Suzanne Bruce
Neil Sadick
Eduardo Tschen
Philip Werschler
Sunil Dhawan
Douglas Farsha
Michael Gold
Scott Guenthner
Steve Kempers
Leon Kircik
Jennifer Parish
Marta Rendon
Phoebe Rich
Linda Stein-Gold
Stephen Tyring
Robert Weiss
Adnan Nasir
Carsten Schmitz
Terry Boodhoo
Alexandre Kaoukhov
David Berk
Fran Cook-Bolden
Ayman Grada

Keywords

Acne Vulgaris, Acne, Sarecycline

Abstract

Abstract not available.

References

Moore A, Green LJ, Bruce S, SadickN, TschenE, WerschlerP, Cook-Bolden FE, DhawanSS, ForshaD, Gold MH, GuenthnerS. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials. Journal of drugs in dermatology: JDD. 2018 Sep;17(9):987-96.

Poster PDF

Published

Sep 2, 2020

DOI https://doi.org/10.25251/skin.4.supp.51

How to Cite

[1]

Moore, A., Bruce, S., Sadick, N., Tschen, E., Werschler, P., Dhawan, S., Farsha, D., Gold, M., Guenthner, S., Kempers, S., Kircik, L., Parish, J., Rendon, M., Rich, P., Stein-Gold, L., Tyring, S., Weiss, R., Nasir, A., Schmitz, C., Boodhoo, T., Kaoukhov, A., Berk, D., Cook-Bolden, F. and Grada, A. 2020. Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-Blind Clinical Trials. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s52. DOI:https://doi.org/10.25251/skin.4.supp.51.

Issue

Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)

Section

Acne & Rosacea

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Author Biography

Alexandre Kaoukhov

Most read articles by the same author(s)

Leon Kircik, Jonathan S Weiss, Kent Allenby, DFD-01, a VCA midpotent beteamethasone dipropionate 0.05% emollient-like spray formulation, demonstrates earlier onset of action compared with a super potent topical steroid for the treatment of moderate psoriasis , SKIN The Journal of Cutaneous Medicine: Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas
Julie C Harper, MD, Leon H Kircik, MD, Michael Gold, MD, Adelaide A Hebert, MD, Jeffrey L Sugarman, MD, PhD, Lawrence Green, MD, Linda Stein Gold, MD, Hilary Baldwin, MD, James Q Del Rosso, DO, Eric Guenin, PharmD, PhD, MPH, Early and Sustained Reductions in Moderate-to-Severe Acne With Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23
Adelaide Hebert, Evan Rieder, Emmy Graber, Hilary Baldwin, Julie C. Harper, Linda Stein Gold, Leon Kircik, Andrew F. Alexis, James Del Rosso, Siva Narayanan, Volker Koscielny, Ismail Kasujee, Richard G. Fried, Acne symptoms and impact of acne on social functioning, emotional functioning, and activities of daily living (ADL) among pediatric patients with moderate to severe non-nodular Acne Vulgaris (AV) in community practices across the U.S: PROSES study , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Linda Stein Gold, Sunil Dhawan, Jonathan Weiss, Zoe D Draelos, Herman Ellman, The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of Phase 2 and Phase 3 Studies , SKIN The Journal of Cutaneous Medicine: Vol. 2 (2018): Supplemental Issue: Scientific Posters Presented at 2018 Winter Clinical Dermatology Conference®-Hawaii
Linda Stein Gold, Kilian Eyerich, Howard Sofen, Pedro Herranz, Leon Kircik, Tony Bewley, Eric Wolf, Gaia Gallo, Yuxin Ding, Fan Emily Yang, Ignasi Pau-Charles, Melinda Gooderham, Lebrikizumab Demonstrates Consistent Efficacy at 16 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis Regardless of Baseline Disease Severity , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 6 (2023): November 2023 Issue
David M Pariser, Lawrence J Green, Edward L Lain, Carsten Schmitz, Amy S Chinigo, Brian McNames, David R Berk, Jamison Hoffman, Ayman Grada, Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
Valerie Callender, Fran Cook-Bolden, Leon Kircik, Jonathan Weiss, Andrew Alexis, Michael Gold, Emil Tanghetti, Hilary Baldwin, Linda Stein Gold, Jeffrey Sugarman, Safety and Tolerability of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants With Acne , SKIN The Journal of Cutaneous Medicine: Vol. 8 No. 1 (2024): January 2024 Issue
Lauren Hoffman, Isabelle Raymond, Leon Kircik, The Effect of Econazole Nitrate Topical Foam, 1% on Signs and Symptoms (Pruritis) of Interdigital Tinea Pedis , SKIN The Journal of Cutaneous Medicine: Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas
Leon Kircik, Zoe Draelos, Linda Stein Gold, Abby Jacobson, Use of Combination Halobetasol Propionate/Tazarotene Lotion in Difficult-to-Treat Psoriasis and TNF-α Mechanism of Action , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Boni Elewski, Alan Menter, Jeffrey Crowley, Stephen Tyring, Yang Zhao, Simon Lowry, Stephen Rozzo, Alan Mendelsohn, Jeffrey Parno, Kenneth Gordon, Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis , SKIN The Journal of Cutaneous Medicine: Vol. 2 (2018): Supplemental Issue: Scientific Posters Presented at 2018 Winter Clinical Dermatology Conference®-Hawaii

<< < 6 7 8 9 10 11 12 13 14 15 > >>

Main Article Content

Keywords

Abstract

References

Article Sidebar

Article Details

Alexandre Kaoukhov

Similar Articles

Most read articles by the same author(s)